Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro models

Infection and Immunity

Volumn 65, Issue 9, 1997, Pages 3713-3718

  Powell, Jan L ^a   Wright, Anita C ^a   Wasserman, Steven S ^a   Hone, David M ^b   Morris Jr , J Glenn ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF HUMAN VIROLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYMYXIN B; POLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL VIRULENCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN SECRETION; SEPTIC SHOCK; VIBRIO VULNIFICUS;

EID: 0030921687     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.9.3713-3718.1997     Document Type: Article

References (40)

1. Bahrani, K., and J. D. Oliver. 1989. Studies on the lipopolysaccharide of virulent and an avirulent strain of Vibrio vulnificus. Biochem. Cell Biol. 68:547-551.
2. Bahrani, K. F., and J. D. Oliver. 1991. Electrophoretic analysis of lipopolysaccharide isolated from opaque and translucent colony variants of Vibrio vulnificus using various extraction methods. Microbios 66:83-93.
3. Benabdelmoumene, S., S. Dumont, C. Petit, P. Poindron, D. Wachsmann, and J. P. Klein. 1991. Activation of human monocytes by Streptococcus mutans serotype f polysaccharide: immunoglobulin G Fc receptor expression and tumor necrosis factor and interleukin-1 production. Infect. Immun. 59:3261-3266.
4. Beutler, B., and G. E. Grau. 1993. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit. Care Med. 21:S423-S435.
5. Blake, P. A., M. H. Merson, R. E. Weaver, D. G. Hollis, and P. C. Heublin. 1979. Disease caused by a marine vibrio: clinical characteristics and epidemiology. N. Engl. J. Med. 300:1-5.
6. Bush, C. A., P. Patel, S. Gunawardena, J. Powell, A. Joseph, J. A. Johnson, and J. G. Morris, Jr. Classification of Vibrio vulnificus strains by the carbohydrate composition of their capsular polysaccharides. Anal. Biochem., in press.
7. Devi, S. J. N., U. Hayat, C. E. Frasch, A. S. Kreger, and J. G. Morris, Jr. 1995. Capsular polysaccharide-protein conjugate vaccines of carbotype 1 Vibrio vulnificus: construction, immunogenicity, and protective efficacy in a murine model. Infect. Immun. 63:2906-2911.
8. Devi, S. J. N., U. Hayat, J. L. Powell, and J. G. Morris, Jr. 1996. Preclinical immunoprophylactic and immunotherapeutic efficacy of antisera to capsular polysaccharide-tetanus toxoid conjugate vaccines of Vibrio vulnificus. Infect. Immun. 64:2220-2224.
9. Espat, N. J., T. Auffenberg, A. Abouhamze, J. Baumhofer, L. L. Moldawer, and R. J. Howard. 1996. A role for tumor necrosis factor-a in the increased mortality associated with Vibrio vulnificus infection in the presence of hepatic dysfunction. Ann. Surg. 223:428-433.
10. Espevik, T., M. Otterlei, G. Skjak-Bræk, L. Ryan, S. D. Wright, and A. Sundan. 1993. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur. J. Immunol. 23:255-261.
11. Gray, L. D., and A. S. Kreger. 1985. Purification and characterization of an extracellular cytolysin produced by Vibrio vulnificus. Infect. Immun. 48:62-72.
12. Hayat, U. Personal communication.
13. Henderson, B., S. Poole, and M. Wilson. 1996. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol. Rev. 60:316-341.
14. Klontz, K. C., S. Lieb, M. Schreiber, H. T. Janowski, L. M. Baldy, and R. A. Gunn. 1988. Syndromes of Vibrio vulnificus infections. Clinical and epidemiological features in Florida cases, 1981-1987. Ann. Intern. Med. 109:318-323.
15. Kothary, M. H., and A. S. Kreger. 1987. Purification and characterization of an elastolytic protease of Vibrio vulnificus. J. Gen. Microbiol. 133:1783-1791.
16. Kreger, A., L. DeChatelet, and P. Shirley. 1981. Interaction of Vibrio vulnificus with human polymorphonuclear leukocytes: association of virulence with resistance to phagocytosis. J. Infect. Dis. 144:244-248.
17. Lagoo-Deenadayalan, S., A. S. Lagoo, W. H. Barber, and K. J. Hardy. 1993. A standardized approach to PCR-based semiquantification of multiple cytokine gene transcripts from small gel samples. Lymphokine Cytokine Res. 12:59-67.
18. Litwin, C. M., T. W. Rayback, and J. Skinner. 1996. Role of catechol siderophore synthesis in Vibrio vulnificus virulence. Infect. Immun. 64:2834-2838.
19. Mancuso, G., F. Tomasello, C. von Hunolstein, G. Orefici, and G. Teti. 1994. Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci. Infect. Immun. 62:2748-2753.
20. McPherson, V. L., J. A. Watts, L. M. Simpson, and J. D. Oliver. 1991. Physiological effects of the lipopolysaccharide of Vibrio vulnificus on mice and rats. Microbios 67:141-149.
21. Mond, J. J., A. Lees, and C. M. Snapper. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:655-692.
22. Onderdonk, A. B., R. B. Markham, D. F. Zaleznik, R. L. Cisneros, and D. L. Kasper. 1982. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intrabdominal abscess model. J. Clin. Invest. 69:9-16.
23. Pantosti, A., A. O. Tzianabos, A. B. Onderdonk, and D. L. Kasper. 1991. Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis. Infect. Immun. 59:2073-2082.
24. Reddy, G. P., U. Hayat, C. Abeygunawardana, C. Fox, A. C. Wright, D. R. Maneval, Jr., C. A. Bush, and J. G. Morris, Jr. 1992. Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus MO6-24. J. Bacteriol. 174:2620-2630.
25. Reddy, G. P., U. Hayat, C. A. Bush, and J. G. Morris, Jr. 1993. Capsular polysaccharide structure of a clinical isolate of Vibrio vulnificus strain BO62316 determined by heteronuclear NMR spectroscopy and high performance anion-exchange chromatography. Anal. Biochcm. 214:106-115.
26. Reddy, G. P., and S. Gunawardena. Unpublished data.
27. Salgado, A., J. L. Boveda, J. Monasterio, R. M. Segura, M. Mourelle, J. Gomez-Jimenez, and R. Peracaula. 1994. Inflammatory mediators and their influence on haemostasis. Haemostasis 24:132-138.
28. Shapiro, M. E., D. L. Kasper, D. F. Zaleznik, S. Spriggs, A. B. Onderdonk, and R. W. Finberg. 1986. Cellular control of abscess formation: role of T cells in the regulation of abscesses formed in response to Bacteroides fragilis. J. Immunol. 137:341-346.
29. Shinoda, S., M. Kobayashi, H. Yamada, S-I. Yoshida, M. Ogawa, and Y. Mizuguchi. 1987. Inhibitory effect of capsular antigen of Vibrio vulnificus on bactericidal activity of human serum. Microbiol. Immunol. 31:393-401.
30. Simonson, J. G., and R. J. Siebeling. 1993. Immunogenicity of Vibrio vulnificus capsular polysaccharides and polysaccharide-protein conjugates. Infect. Immun. 61:2053-2058.
31. Simpson, L. M., V. K. White, S. F. Zane, and J. D. Oliver. 1987. Correlation between virulence and colony morphology in Vibrio vulnificus. Infect. Immun. 55:269-272.
32. Simpson, S. Q., R. Singh, and D. E. Bice. 1994. Heat-killed pneumococci and pneumococcal capsular polysaccharides stimulate tumor necrosis factor-α production by murine macrophages. Am. J. Respir. Cell Mol. Biol. 10:284-289.
33. Soell, M., M. Diab, G. Haan-Archipoff, A. Beretz, C. Herbelin, B. Poutrel, and J.-P. Klein. 1995. Capsular polysaccharide types 5 and 8 of Staphylococcus aureus hind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines. Infect. Immun. 63:1380-1386.
34. Soell, M., E. Lett, F. Holveck, M. Scholler, D. Wachsmann, and J-P. Klein. 1995. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-α release. J. Immunol. 154:851-860.
35. Takahashi, T., T. Nishihara, Y. Ishihara, K. Amano, N. Shibuya, I. Moro, and T. Koga. 1991. Murine macrophage interleukin-1 release by capsularlike serotype-specific polysaccharide antigens of Actinobacillus actinomycetemcomitans. Infect. Immun. 59:18-23.
36. Tzianabos, A. O., A. B. Onderdonk, B. Rosner, R. L. Cisneros, and D. L. Kasper. 1993. Structural features of polysaccharides that induce intra-abdominal abscesses. Science 262:416-419.
37. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides. Extraction with phenol-water and further applications, p. 83-91. In L. Whistler (ed.), Methods in carbohydrate chemistry. Academic Press Inc., New York, N.Y.
38. Wright, A. C., L. M. Simpson, K. Richardson, D. R. Maneval, Jr., J. D. Oliver and J. G. Morris, Jr. 1986. Siderophore production and outer membrane proteins of selected Vibrio vulnificus strains under conditions of iron limitation. FEMS Microb. Lett. 35:255-260.
39. Wright, A. C., L. M. Simpson, J. D. Oliver, and J. G. Morris, Jr. 1990. Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus. Infect. Immun. 58:1769-1773.
40. Yoshida, S.-I., M. Ogawa, and Y. Mizuguchi. 1985. Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus. Infect. Immun. 47:446-451.